Remedee Labs

Medical Devices & EquipmentSeries BSaint-Martin, Franceremedeelabs.com

Latest round

Series B

Last raised

May 2022

Total raised

$17M

Investors

10

About Remedee Labs

Founded in 2016 by David Crouzier and Michael Foerster, Remedee Labs SA is headquartered in Saint-Martin, France. The company focuses on developing non-pharmacological solutions for chronic pain management.Remedee Labs specializes in innovative, non-pharmacological medical devices designed to alleviate chronic pain and enhance overall well-being. Their flagship product, the Remedee bracelet, utilizes advanced millimeter-wave neuromodulation technology to stimulate the secretion of endorphins, the body's natural painkillers. This device is clinically validated and aims to address various conditions, particularly osteoarthritis and fibromyalgia, by modulating the central nervous system's activity to reduce pain intensity and improve associated symptoms like sleep and fatigue. The company has introduced two primary solutions: Novi Rem™, tailored for patients suffering from osteoarthritis, and Fibro Rem™, specifically designed for fibromyalgia sufferers.40. The company generates revenue through the sale of its medical devices, notably the Novi Rem™ and Fibro Rem™, marketed directly to consumers as well as healthcare providers. The business model is structured around direct-to-consumer sales, leveraging partnerships with healthcare professionals to promote the effectiveness of their products. The company is working on upcoming product launches aimed at improving patient outcomes in chronic pain management. Additionally, Remedee Labs aims to enter new markets beyond France, targeting European and potential international regions by 2025. The investment received from Generali France will support these initiatives and facilitate the development of further innovative solutions.

Who invested in Remedee Labs

10 investors across 2 rounds

See all investors in Remedee Labs

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    May 24, 2022

    Amount

    $11M

    Investors

    Locked

  2. Series A

    Jun 3, 2019

    Amount

    $5.8M

    Investors

    Locked

Questions about Remedee Labs

Who invested in Remedee Labs?

Remedee Labs has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Remedee Labs raised?

Remedee Labs has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Remedee Labs last raise money?

Remedee Labs's most recent round on record is a Series B, in May 2022.

What does Remedee Labs do?

Founded in 2016 by David Crouzier and Michael Foerster, Remedee Labs SA is headquartered in Saint-Martin, France.

Where is Remedee Labs headquartered?

Remedee Labs is headquartered in Saint-Martin, France.

Which VCs invest in companies like Remedee Labs?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Remedee Labs's stage. Their profiles are linked below.

Raising like Remedee Labs? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.